Effects of growth hormone administration in human obesity

Obesity Research

Volumn 11, Issue 2, 2003, Pages 170-175

  Shadid, Samyah ^a   Jensen, Michael D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Body composition; Free fatty acids; Glucose tolerance; Insulin; Visceral fat

Indexed keywords

HUMAN GROWTH HORMONE;

ADIPOSE TISSUE; BODY COMPOSITION; CALORIC INTAKE; CLINICAL TRIAL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; OBESITY; PHYSIOLOGY; REVIEW;

ADIPOSE TISSUE; BODY COMPOSITION; CLINICAL TRIALS; DIET, REDUCING; ENERGY INTAKE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; OBESITY;

EID: 0043231590     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.27     Document Type: Article

References (28)

1. Münzer T, Harman SM, Hees P, et al. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab. 2001;86:3604-10.
2. Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord. 1999;23:260-71.
3. Norrelund H, Borglum J, Jorgensen JO, et al. Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women. Clin Endocrinol (Oxf). 2000;52:305-12.
4. Kim KR, Nam SY, Song YD, Lim SK, Lee HC, Huh KB. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Horm Res. 1999;51:78-84.
5. Johannsson G, Mårin P, Lönn L, et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 1997;82:727-34.
6. Mauras N, O'Brien KO, Welch S, et al. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab. 2000;85:1686-94.
7. Richelsen B, Pedersen SB, Kristensen K, et al. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism. 2000;49:906-11.
8. Bengtsson B-A, Brummer R-JM, Edén S, Sjöström L. Effects of growth hormone on fat mass and fat distribution. Acta Paediatr. 1992;383:62-5.
9. Slavin BG, Ong JM, Kern PA. Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res. 1994;35:1535-41.
10. DiGirolamo M, Eden S, Enberg G, et al. Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes. FEBS Lett. 1986;205:15-9.
11. Maccario M, Grottoli S, Procopio M, et al. The GH/IGF-I axis in obesity: Influence of neuro-endocrine and metabolic factors. Int J Obes Relat Metab Disord. 2000;24:S96-S9.
12. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73:1081-8.
13. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 1991;72:51-9.
14. Richelsen B, Pedersen SB, Børglum JD, Møller-Pedersen T, Jørgensen J, Jørgensen JO. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am J Physiol. 1994;266:E211-E6.
15. Tagliaferri M, Scacchi M, Pincelli AI, et al. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. Int J Obes Relat Metab Disord. 1998;22:836-41.
16. Snyder DK, Clemmons DR, Underwood LE. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects on anabolism, lipolysis, and body composition. J Clin Endocrinol Metab. 1988;67:54-61.
17. Snyder DK, Underwood LE, Clemmons DR. Persistent lipolytic effect of exogenous growth hormone during caloric restriction. Am J Med. 1995;98:129-34.
18. Drent ML, Wever LDV, Adèr HJ, van der Veen EA. Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects. Eur J Endocrinol. 1995;132:565-72.
19. Snyder DK, Underwood LE, Clemmons DR. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. Am J Clin Nutr. 1990;52:431-7.
20. Skaggs SR, Crist DM. Exogenous human growth hormone reduces body fat in obese women. Horm Res. 1991;35:19-24.
21. Thompson JL, Butterfield GE, Gylfadottir UK, et al. Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab. 1998;83:1477-84.
22. Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab. 2000;85:970-6.
23. Brummer R-JM. Effects of growth hormone treatment on visceral adipose tissue. Growth Horm IGF Res. 1998;8:19-23.
24. Russell-Jones DL, Bowes SB, Rees SE, et al. Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults. Am J Physiol. 1998;274:E1050-E6.
25. Clemmons DR, Snyder DK, Williams R, Underwood LE. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab. 1987;64:878-83.
26. Snyder DK, Clemmons DR, Underwood LE. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans. J Clin Endocrinol Metab. 1989;69:745-52.
27. Nam SY, Kim KR, Cha BS, et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 2001;25:1101-7.
28. Gerard JM, Garibaldi L, Myers SE, et al. Sleep apnea in patients receiving growth hormone. Clin Pediatr. 1997;36:321-6.